XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps

ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical trial program also showed reduction in sinus inflammation and in acute exacerbations, which…#reopen #xhance #yardley #optn #fda #sciatica #rickchandra #rolandroneavey #vanderbiltuniversity #ramymahmoud
Source: Reuters: Health - Category: Consumer Health News Source Type: news